Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab
NCT ID: NCT07087743
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-07-25
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A total of 30 participants (15 stroke, 15 healthy controls) aged 20 years or older will undergo single-session gait training using the VR-robot system. Participants will be assessed using spatiotemporal gait parameters, muscle activity, foot pressure, and vertical ground reaction forces. Additional safety measures-including a saddle-type weight support and real-time heart rate monitoring via smartwatch-are implemented to ensure a safe and controlled training environment. This study aims to test the feasibility and effectiveness of this VR-based system in improving gait symmetry and functional walking capacity in people recovering from stroke.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Rehabilitation Robots-Morning Walk in Individuals With Hemiparesis
NCT06374706
Resume Walking by an Interactive Mobile Robot of Rehabilitation After Vascular Stroke (Cerebral Vascular Stroke) in Combination With Traditional Reeducation
NCT03686280
Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training
NCT00075283
Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage
NCT05423626
Virtual Reality-Enhanced Rehabilitation for Upper Limb Recovery in Acute Post-Stroke Patients
NCT07254676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
People with hemiparetic stroke often exhibit gait asymmetry due to reduced propulsion from the paretic leg. This contributes to overreliance on the non-paretic leg and leads to inefficient, energy-consuming walking patterns. Traditional rehabilitation, including robot-assisted gait training, typically emphasizes repetitive motion but lacks a specific focus on propulsion, limiting its potential to promote neuroplasticity and symmetrical gait.
To address this limitation, the research team has developed a Virtual Reality (VR)-based visual feedback system that delivers real-time, individualized cues aimed at improving paretic limb propulsion. This system is integrated into the Morning Walk® end-effector rehabilitation robot developed by CUREXO. By encouraging active use of the paretic limb, the intervention is designed to reduce compensatory movement strategies and improve gait symmetry.
Study Objectives:
The primary objective is to evaluate the feasibility and effectiveness of this VR-enhanced limb propulsion training system. The study compares spatiotemporal gait parameters between individuals post-stroke and healthy controls, with the goal of determining whether real-time visual feedback can improve bilateral coordination and reduce asymmetry.
Participants:
A total of 30 participants (15 post-stroke, 15 healthy) aged 20 years or older will be recruited. Stroke participants must have experienced a stroke at least one month prior to enrollment and be able to walk at least 10 meters with or without assistive devices. Healthy controls must walk independently without assistance.
Methods:
Each participant will complete a single-session gait training protocol with pre- and post-assessments. Equipment used includes:
Zeno Walkway: Overground gait mat to assess spatiotemporal gait parameters before and after training.
Morning Walk® Robot: End-effector rehabilitation device with integrated VR propulsion visual feedback system.
Delsys EMG Sensors: For analysis of bilateral lower extremity muscle activity.
Tekscan In-Shoe Sensors: To measure ground reaction forces and foot pressure during walking.
Smartwatch Monitoring: To track heart rate during training as an indicator of exertion (data not stored or transmitted).
Procedures:
Baseline Assessments: Collection of demographic data, health history, physical function, height, and weight.
Pre-Training Gait Assessment: Overground walking trials using the Zeno Walkway.
VR Robot Gait Training: Participants walk with the Morning Walk® robot while receiving propulsion-related visual feedback in VR.
Post-Training Gait Assessment: Re-evaluation using the Zeno Walkway to assess changes in gait performance.
Data Collection:
Real-time biomechanical data (spatiotemporal parameters, EMG, and foot pressure/GRFs) will be collected and analyzed. Smartwatch data will only be viewed during the session and will not be stored.
Risks and Safety:
Risks are minimal. The Morning Walk® robot features a saddle-type support system and protective surrounds to prevent falls. Minor skin irritation may occur from EMG electrodes. All data will be stored securely on password-protected devices.
Significance:
This study is the first to integrate a VR-based propulsion feedback system into an end-effector gait training robot. It is expected to enhance paretic limb engagement, promote symmetrical gait patterns, and support motor learning through individualized feedback and neuroplastic adaptation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-Stroke Group
Individuals who have had a stroke will complete a single session of VR-integrated gait training using the Morning Walk® end-effector robot. Gait performance will be evaluated before and after training.
VR-Based Gait Training with End-Effector Robot
A single-session gait training protocol using the Morning Walk® end-effector robot with real-time virtual reality visual feedback to encourage paretic limb propulsion and symmetrical gait. This intervention is intended to study participants' behavioral and biomechanical responses to the VR feedback, not to evaluate the robot as a device.
Healthy Group
Healthy participants will undergo the same single-session VR-integrated gait training using the Morning Walk® end-effector robot. Pre- and post-training assessments will be conducted.
VR-Based Gait Training with End-Effector Robot
A single-session gait training protocol using the Morning Walk® end-effector robot with real-time virtual reality visual feedback to encourage paretic limb propulsion and symmetrical gait. This intervention is intended to study participants' behavioral and biomechanical responses to the VR feedback, not to evaluate the robot as a device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR-Based Gait Training with End-Effector Robot
A single-session gait training protocol using the Morning Walk® end-effector robot with real-time virtual reality visual feedback to encourage paretic limb propulsion and symmetrical gait. This intervention is intended to study participants' behavioral and biomechanical responses to the VR feedback, not to evaluate the robot as a device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For post-stroke participants:
* Diagnosis of stroke at least 1 month prior to participation.
* Able to walk at least 10 meters with or without assistive devices.
For healthy participants:
° Must walk independently without assistive devices.
Exclusion Criteria
* Comatose individuals.
* Individuals unable to follow three-step commands.
* Individuals with lower limb amputation.
* Individuals with poorly controlled diabetes (e.g., foot ulceration).
* Individuals with legal blindness.
* Individuals with progressive neurological conditions.
* Medically unstable individuals.
* Individuals with significant musculoskeletal impairments.
* Individuals with congestive heart failure or unstable angina.
* Individuals with peripheral vascular disease.
* Individuals with severe neuropsychiatric disorders (e.g., dementia, cognitive deficits, or severe depression).
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Medical Branch, Galveston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Medical Branch
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mansoo Ko
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-0065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.